Sipa1 deficiency–induced bone marrow niche alterations lead to the initiation of myeloproliferative neoplasm

New research explores signal-induced proliferation-associated gene 1 (SIPA1) mutations, the role they play in initiation MPNs, and the potential to use this gene for future MPN therapies.

 Blood Advances

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.